Kembali ke Daftar Obat
Panduan penyiapan dan pemberian terapi injeksi
Panduan penyiapan dan pemberian terapi injeksi
Amiodarone Hydrochloride
Risiko Phlebitis tinggi
Kejadian Sering (1/10 – 1/100 kejadian)
Harap perhatikan informasi penyiapan dan pemberian terapi dengan seksama.
Penyiapan
Sediaan
- 50mg/ml
Rekomendasi Pengenceran (Konsentrasi)
1-6mg/ml (maksimal 2 ampul@3cc dalam 50cc)
Pelarut
- D5%
Pemberian
Rekomendasi Akses
Konsentrasi pengenceran >2mg/ml disarankan menggunakan CVC
Rekomendasi Durasi Pemberian
Dengan infus pump sesuai dosis
Stabilitas Obat Setelah Rekonstruksi
24 jam dalam suhu 23 C
Keamanan
pH
4,08
pH risiko sedang (4,0-5,0 / 7,5-9,0)
Phlebitis
Ya
Sering (1/10 – 1/100 kejadian)
Harap perhatikan informasi penyiapan dan pemberian terapi dengan seksama.
Harap perhatikan informasi penyiapan dan pemberian terapi dengan seksama.
Inkompatibilitas
-
Floxacilin Sodium
-
Furosemide
-
Quinidine Gluconate
-
Heparin Sodium
-
Pantoprazole Sodium
-
Aminophylline
-
Amoxicillin Sodium
-
Ampicillin Sodium
-
Argatroban
-
Bivalirudin
-
Cefazolin
-
Ceftazidime
-
Clevidipine Butyrate
-
Digoxin
-
Imipenem–Cilastatin Sodium
-
Letermovir
-
Magnesium Sulfate
-
Meropenem
-
Micafungin Sodium
-
Piperacillin Sodium–Tazobactam Sodium
-
Plazomicin Sulfate
-
Potassium Phosphates
-
Sodium Bicarbonate
-
Sodium Nitroprusside
-
Sodium Phosphates
- Sugammadex Sodium
Klasifikasi GHS
Irritant
Health Hazard
Manifestasi GHS
H312 (89.7%): Harmful in contact with skin [Warning Acute toxicity, dermal]
H332 (88.8%): Harmful if inhaled [Warning Acute toxicity, inhalation]
H373 (10.3%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]
H332 (88.8%): Harmful if inhaled [Warning Acute toxicity, inhalation]
H373 (10.3%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]
Sumber
- American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850
- https://pubchem.ncbi.nlm.nih.gov/compound/441325
- Manrique-Rodríguez, S., Heras-Hidalgo, I., Pernia-López, M.S. et al. Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety. Drugs R D 21, 39–64 (2021). https://doi.org/10.1007/s40268-020-00329-w